Xu, Liangliang
Feng, Xinfu
Hao, Xiangyong
Wang, Peng
Zhang, Yanfang
Zheng, Xiaobo
Li, Lian
Ren, Shengsheng
Zhang, Ming
Xu, Mingqing
Funding for this research was provided by:
National Natural Science Foundation of China (71673193)
Key Technology Research and Development Program of the Sichuan Province (2015SZ0131, 2017FZ0082, 19ZDYF1740)
Natural Science Foundation for Young Scientists and the Science & Technology Planning Project of Gansu Province (18JR3RA058)
Chinese foundation for hepatitis prevention and control——TianQing liver disease research fund subject (TQGB20190202)
Article History
Received: 12 September 2018
Accepted: 15 January 2019
First Online: 22 February 2019
Ethics approval and consent to participate
: The collection of human specimens was approved by the Biomedical Ethics Committee of West China Hospital and the written informed consent were obtained from each patient.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.